What changed in Ge Healthcare Technologies Inc.'s latest annual report
In the year ended 31 Dec 2025, Ge Healthcare Technologies Inc.'s revenue rose 4.8% to USD 20.62bn, from USD 19.67bn; net income rose 4.6% to USD 2.08bn, from USD 1.99bn; cash and cash equivalents rose 56.3% to USD 4.49bn, from USD 2.87bn.
Year ended 31 Dec 2025. Source: 10-K filed 4 Feb 2026, read it on SEC EDGAR.
USD 19.67bn to USD 20.63bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 19.67bn | 20.63bn | Up 4.8% |
| Net income | 1.99bn | 2.08bn | Up 4.6% |
| Total assets | 33.09bn | 36.91bn | Up 11.5% |
| Total liabilities | 24.44bn | 26.31bn | Up 7.7% |
| Long-term debt | 7.45bn | 9.49bn | Up 27.5% |
| Cash and cash equivalents | 2.87bn | 4.49bn | Up 56.3% |
| Shareholders' equity | 8.45bn | 10.38bn | Up 22.9% |
Questions people ask
Did Ge Healthcare Technologies Inc.'s revenue grow last year?
Revenue grew 4.8%, from USD 19.67bn to USD 20.63bn in the year ended 31 Dec 2025.
Is Ge Healthcare Technologies Inc. profitable?
Yes. Net income was USD 2.08bn in the year ended 31 Dec 2025. The year before: USD 1.99bn.
How much cash and debt does Ge Healthcare Technologies Inc. have?
At its latest year end (31 Dec 2025), Ge Healthcare Technologies Inc. reported cash and cash equivalents of USD 4.49bn and long-term debt of USD 9.49bn.
Where do these numbers come from?
From Ge Healthcare Technologies Inc.'s own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Ge Healthcare Technologies Inc.?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demo